All data are based on the daily closing price as of February 16, 2026
i

Ildong Pharmaceutical

249420.KO
25.00 USD
-0.49
-1.92%

Overview

Last close
25.00 usd
Market cap
787.58M usd
52 week high
30.05 usd
52 week low
7.11 usd
Target price
34.76 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
1.9759
Price/Book Value
4.9009
Enterprise Value
857.26M usd
EV/Revenue
2.1421
EV/EBITDA
20.7025

Key financials

Revenue TTM
407.48M usd
Gross Profit TTM
153.89M usd
EBITDA TTM
27.91M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
409.71M usd
Net debt
56.91M usd

About

Ildong Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in South Korea. The company offers active lactic acid bacterial and anti-diarrheal agents, antibiotics, antifungal and antiviral products, anti-cancer, antineoplastic agents, and NSAIDs and analgesics, as well as vitamins, minerals, and nutrients; and drugs for blood circulation, cardiovascular and central nervous system, dental, endocrine and metabolic system, gastrointestinal system, respiratory system, and urogenital system applications. It also provides raw material drugs; health foods and foods; beverages; cosmetics; medical devices for scar treatment; and other drugs for treating thick wounds, osteoarthritis, periarthritis of shoulder, and artificial tears, as well as feminine cleanser products. The company was founded in 1941 and is headquartered in Seoul, South Korea.
  • Symbol
    249420.KO
  • Exchange
    KO
  • Isin
    KR7249420001
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
    Yun Paul Woongsup
  • Headquarter
    Seoul
  • Web site
    https://www.ildong.com
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top